Seattle, WA · Founded 2015 · Privately Held (backing)
Developer of a human stem cell-based platform designed to facilitate the discovery of medicines by integrating human cells, systems, and data. Curi Bio is based in Seattle, WA and was founded in 2015. Its last reported valuation was $62 million in Dec 2025. It has raised $20.1 million.
Last reported valuation
$62.0M
Oct 2026
Priced at
—
Total raised
$20.1M
Last round
—
Cap table — not yet on record
Curi Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Curi Bio with a free account
·The complete investor list: 13 names
·Watch Curi Bio: the Monday email on marks, rounds and moves
